clinical trial · NCT07313852

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center →·phase2·not yet recruiting·n = 26

B-cell Acute Lymphoblastic LeukemiaB-Cell Acute Lymphoblastic Leukemia, AdultB-ALLBlinatumomab Injection

brief summary

The purpose of this study is to find out whether combining inotuzumab and blinatumomab is a safe and effective treatment for participants with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL).

started

Jun 1, 2026

primary completion

Jan 1, 2029

completion

Jan 1, 2029

last updated

Jun 16, 2026

official title

A Phase 1/2 Study of Concurrent Inotuzumab and Subcutaneous Blinatumomab in Adult Patients With B-cell Acute Lymphoblastic Leukemia

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol